Skip to main content
logo
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.700
-0.570 (-13.35%)
At close: Oct 6, 2026, 4:00 PM EDT
3.640
-0.060 (-1.62%)
After-hours: Oct 6, 2026, 4:52 PM EDT

Aclaris Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
545326265741,050890
Market Cap Growth
170.29%22.88%256.84%-92.92%17.97%220.59%
Enterprise Value
37616195-110805650
Last Close Price
4.273.012.481.0515.7514.54

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
72.0941.6714.182.3835.30131.67
PB Ratio
4.793.161.710.475.324.51
P/TBV Ratio
4.763.161.710.475.514.68

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
51.5520.595.06-27.0496.09

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.020.020.010.02
Net Debt / Equity Ratio
-1.35-1.45-1.29-1.13-1.15-1.13
Net Debt / EBITDA Ratio
1.972.023.861.56-3.42
Net Debt / FCF Ratio
2.713.169.972.243.344.25
Asset Turnover
0.050.040.090.140.120.04
Quick Ratio
3.463.363.993.869.948.38
Current Ratio
3.463.363.994.1610.568.94
Return on Equity (ROE)
-59.10%-50.20%-84.46%-49.88%-44.01%-77.33%
Return on Assets (ROA)
-28.98%-24.32%-15.72%-31.67%-21.04%-25.38%
Return on Capital Employed (ROCE)
-56.50%-56.20%-27.80%-68.80%-36.60%-28.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.78%-19.91%-49.76%-118.96%-8.28%-10.21%
FCF Yield
-10.49%-14.48%-7.61%-107.07%-6.49%-5.89%
Buyback Yield / Dilution
-25.53%-58.56%-10.73%-7.05%-14.95%-33.36%
SEC Filings: 10-K · 10-Q